Extrastriatal binding of [123I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls

PurposeApart from binding to the dopamine transporter (DAT), [123I]FP-CIT shows moderate affinity for the serotonin transporter (SERT), allowing imaging of both monoamine transporters in a single imaging session in different brain areas. The aim of this study was to systematically evaluate extrastriatal binding (predominantly due to SERT) and its age and gender dependencies in a large cohort of healthy controls.MethodsSPECT data from 103 healthy controls with well-defined criteria of normality acquired at 13 different imaging centres were analysed for extrastriatal binding using volumes of interest analysis for the thalamus and the pons. Data were examined for gender and age effects as well as for potential influence of striatal DAT radiotracer binding.ResultsThalamic binding was significantly higher than pons binding. Partial correlations showed an influence of putaminal DAT binding on measured binding in the thalamus but not on the pons. Data showed high interindividual variation in extrastriatal binding. Significant gender effects with 31 % higher binding in women than in men were observed in the thalamus, but not in the pons. An age dependency with a decline per decade (±standard error) of 8.2 ± 1.3 % for the thalamus and 6.8 ± 2.9 % for the pons was shown.ConclusionThe potential to evaluate extrastriatal predominant SERT binding in addition to the striatal DAT in a single imaging session was shown using a large database of [123I]FP-CIT scans in healthy controls. For both the thalamus and the pons, an age-related decline in radiotracer binding was observed. Gender effects were demonstrated for binding in the thalamus only. As a potential clinical application, the data could be used as a reference to estimate SERT occupancy in addition to nigrostriatal integrity when using [123I]FP-CIT for DAT imaging in patients treated with selective serotonin reuptake inhibitors.

[1]  Tae-Wan Jung,et al.  No volume difference of medulla oblongata between young and old Korean people , 2009, Brain Research.

[2]  G. Vauquelin,et al.  [3H]GBR 12935 Binding to Dopamine Uptake Sites in the Human Brain , 1989, Journal of neurochemistry.

[3]  A. Alavi,et al.  123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  Lee-Tzuu Chang,et al.  A Method for Attenuation Correction in Radionuclide Computed Tomography , 1978, IEEE Transactions on Nuclear Science.

[5]  Mark Slifstein,et al.  Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[6]  R Coppola,et al.  Reduced central serotonin transporters in alcoholism. , 1998, The American journal of psychiatry.

[7]  G. Defazio,et al.  Midbrain SERT in degenerative parkinsonisms: A 123I‐FP‐CIT SPECT study , 2010, Movement disorders : official journal of the Movement Disorder Society.

[8]  J S Fowler,et al.  Decreased dopamine transporters with age in healthy human subjects , 1994, Annals of neurology.

[9]  J. Marcusson,et al.  Age stability of human brain 5-HT terminals studied with [3H]paroxetine binding. , 1992, Gerontology.

[10]  B. Winblad,et al.  5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disorders , 1987, Brain Research.

[11]  K. Laere,et al.  European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  Michael J. Bannon,et al.  Age‐related and regional differences in dopamine transporter mRNA expression in human midbrain , 1997, Neurology.

[13]  Koen Van Laere,et al.  EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2 , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  Jan Booij,et al.  The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism , 2001, European Journal of Nuclear Medicine.

[15]  T. Di Paolo,et al.  Oestradiol Modulation of Serotonin Reuptake Transporter and Serotonin Metabolism in the Brain of Monkeys , 2013, Journal of neuroendocrinology.

[16]  J D Speelman,et al.  One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  D. Collins,et al.  Automatic 3D Intersubject Registration of MR Volumetric Data in Standardized Talairach Space , 1994, Journal of computer assisted tomography.

[18]  G. Knudsen,et al.  Serotonin Transporters in Dopamine Transporter Imaging: A Head-to-Head Comparison of Dopamine Transporter SPECT Radioligands 123I-FP-CIT and 123I-PE2I , 2010, The Journal of Nuclear Medicine.

[19]  P B Hoffer,et al.  SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  F. L. Rocha,et al.  Antidepressants for depression in Parkinson’s disease: systematic review and meta-analysis , 2013, Journal of psychopharmacology.

[21]  J. Marcusson,et al.  High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue , 1989, Brain Research.

[22]  Vibe G. Frokjaer,et al.  Serotonin transporter binding in the hypothalamus correlates negatively with tonic heat pain ratings in healthy subjects: A [11C]DASB PET study , 2011, NeuroImage.

[23]  D. Bailey,et al.  CT-based quantitative SPECT for the radionuclide 201Tl: experimental validation and a standardized uptake value for brain tumour patients , 2012, Cancer imaging : the official publication of the International Cancer Imaging Society.

[24]  J. Seibyl,et al.  Age-related decline in central serotonin transporter availability with [123I]β-CIT SPECT , 2000, Neurobiology of Aging.

[25]  J Tauscher,et al.  Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  Robert B. Innis,et al.  Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors , 2004, Biological Psychiatry.

[27]  T. Su,et al.  Imaging the serotonin transporter using 123I-ADAM in the human brain , 2009, Psychiatry Research: Neuroimaging.

[28]  Antti Sohlberg,et al.  Optimal collimator design for cardiac SPECT when resolution recovery is applied in statistical reconstruction , 2007 .

[29]  Siegfried Kasper,et al.  Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas , 2012, NeuroImage.

[30]  Janet R. Saffer,et al.  Effects of age on dopamine transporters in healthy humans. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  L. Reneman,et al.  Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers , 2000, European Journal of Nuclear Medicine.

[32]  Eric C Frey,et al.  Model-based compensation for quantitative 123I brain SPECT imaging , 2006, Physics in medicine and biology.

[33]  H. Möller,et al.  [I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects. , 2007, Journal of psychiatry & neuroscience : JPN.

[34]  Yoshiro Okubo,et al.  No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET , 2003, Synapse.

[35]  Ralph Buchert,et al.  Is correction for age necessary in SPECT or PET of the central serotonin transporter in young, healthy adults? , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  J. Cummings,et al.  [123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane single-photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies , 2012, Alzheimer's & Dementia.

[37]  L. Covi,et al.  SCL-90: an outpatient psychiatric rating scale--preliminary report. , 1973, Psychopharmacology bulletin.

[38]  A. Fischman,et al.  Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain , 1998, Synapse.

[39]  D. Mash,et al.  Visualizing Dopamine and Serotonin Transporters in the Human Brain with the Potent Cocaine Analogue [125I]RTI‐55: In Vitro Binding and Autoradiographic Characterization , 1994, Journal of neurochemistry.

[40]  W. Koch,et al.  Loss of dopamine transporter binding in Parkinson's disease follows a single exponential rather than linear decline. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[41]  Jan Booij,et al.  Brain kinetics of the new selective serotonin transporter tracer [(123)I]ADAM in healthy young adults. , 2006, Nuclear medicine and biology.

[42]  Markus Nowak Lonsdale,et al.  Proposal for the standardisation of multi-centre trials in nuclear medicine imaging: prerequisites for a European 123I-FP-CIT SPECT database , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[43]  S. Gacinovic,et al.  Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]‐FP‐CIT SPECT imaging: The [123I]‐FP‐CIT study group , 2000, Movement disorders : official journal of the Movement Disorder Society.

[44]  J. Seibyl,et al.  Age-related decline in central serotonin transporter availability with [(123)I]beta-CIT SPECT. , 2000, Neurobiology of aging.

[45]  E. Fliers,et al.  Imaging of serotonin transporters with [123I]FP-CIT SPECT in the human hypothalamus , 2013, EJNMMI Research.

[46]  D. Guilloteau,et al.  Visualization of the Dopamine Transporter in the Human Brain Postmortem with the New Selective Ligand [125I]PE2I , 1999, NeuroImage.

[47]  Faith M. Gunning-Dixon,et al.  Age and sex differences in the cerebellum and the ventral pons: a prospective MR study of healthy adults. , 2001, AJNR. American journal of neuroradiology.

[48]  Jianjun Sun,et al.  Dopamine D1, D2, D3 Receptors, Vesicular Monoamine Transporter Type-2 (VMAT2) and Dopamine Transporter (DAT) Densities in Aged Human Brain , 2012, PloS one.

[49]  C. Halldin,et al.  Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain , 2004, Human brain mapping.

[50]  E. Ryding,et al.  A new model for separation between brain dopamine and serotonin transporters in 123I-β-CIT SPECT measurements: normal values and sex and age dependence , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[51]  Marc Laruelle,et al.  Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites , 1988, Biological Psychiatry.

[52]  S. Amir,et al.  A role for serotonin in the circadian system revealed by the distribution of serotonin transporter and light-induced Fos immunoreactivity in the suprachiasmatic nucleus and intergeniculate leaflet , 1998, Neuroscience.

[53]  Johannes Schwarz,et al.  Monoamine transporter availability in Parkinson’s disease patients with or without depression , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[54]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[55]  E. van de Giessen,et al.  The SPECT tracer [123I]ADAM binds selectively to serotonin transporters: a double-blind, placebo-controlled study in healthy young men , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[56]  Markus Nowak Lonsdale,et al.  Calibration of gamma camera systems for a multicentre European 123I-FP-CIT SPECT normal database , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[57]  S. L. la Fleur,et al.  Assessing the Optimal Time Point for the Measurement of Extrastriatal Serotonin Transporter Binding with 123I-FP-CIT SPECT in Healthy, Male Subjects , 2012, The Journal of Nuclear Medicine.

[58]  M Fujita,et al.  Sex differences in [123I]β‐CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers , 2001, Synapse.

[59]  H Watabe,et al.  Acceleration of Monte Carlo-based scatter compensation for cardiac SPECT. , 2008, Physics in medicine and biology.

[60]  J. De Keyser,et al.  Age‐related changes in the human nigrostriatal dopaminergic system , 1990, Annals of neurology.

[61]  N. Sims,et al.  Biochemical Evidence of Selective Nerve Cell Changes in the Normal Ageing Human and Rat Brain , 1983, Journal of neurochemistry.

[62]  I. Moilanen,et al.  Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents , 2000, Molecular Psychiatry.

[63]  B. Winblad,et al.  Elevated Density of [3H]Imipramine Binding in Aged Human Brain , 1985, Journal of neurochemistry.

[64]  J. Marcusson,et al.  Effect of aging in human cortical pre- and postsynaptic serotonin binding sites , 1993, Brain Research.

[65]  J. Booij,et al.  Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[66]  Ulrich Müller,et al.  Is correction for age necessary in neuroimaging studies of the central serotonin transporter? , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[67]  J. Tiihonen,et al.  Effects of ageing on serotonin transporters in healthy females , 2001, European Journal of Nuclear Medicine.